🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is Page 4

Can we talk about how SLOW the FDA is

KarenAZ_mom Mon, Apr 20, 2026 at 10:27 AM 38 replies 1,036 viewsPage 4 of 8
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Apr 24, 2026 at 12:41 AM#16

Clinical perspective, offered as context rather than as advice. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Apr 24, 2026 at 3:41 AM
31 6jim_asheville, matt_MKE, Dr.ReproEndo and 28 others
Reply Quote Save Share Report
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
Apr 24, 2026 at 12:39 PM#17

One thing that is still open after wendy_avl’s answer:

How long did you give it before you decided it was working?

Last edited: Apr 24, 2026 at 1:39 PM
30 5AmyNC_wife, SkepticalSean, Dr.CardioMD and 27 others
Reply Quote Save Share Report
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Apr 25, 2026 at 12:37 AM#18
DeniseRN_TPA said:
It helps to say which part of this you are uncertain about.

Pushing back on DeniseRN_TPA here. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.

Ask again with the specifics and you will get a better answer than this one.

29 4TomTeleRx, DoseLogDan, SleepFixSam and 26 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
pam_columbus
Member
312
1,345
Aug 2024
Columbus, OH
Apr 25, 2026 at 12:34 PM#19
DeniseRN_TPA said:
It helps to say which part of this you are uncertain about.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

28 3tammy_FL, Dr.LipidDallas, alex_tucson and 25 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Apr 26, 2026 at 12:32 AM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. No action needed from anybody.

6 6PurityPaulOR, MaxMetOK, MounjBrad and 3 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register